PÁCAL, Lukáš, Katarína KURICOVÁ a Kateřina KAŇKOVÁ. Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation? World Journal of Diabetes. Pleasanton: Baishideng Publishing Group Inc., 2014, roč. 5, č. 3, s. 288-295. ISSN 1948-9358.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation?
Autoři PÁCAL, Lukáš (203 Česká republika, garant, domácí), Katarína KURICOVÁ (703 Slovensko, domácí) a Kateřina KAŇKOVÁ (203 Česká republika, domácí).
Vydání World Journal of Diabetes, Pleasanton, Baishideng Publishing Group Inc. 2014, 1948-9358.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Kód RIV RIV/00216224:14110/14:00080141
Organizační jednotka Lékařská fakulta
Klíčová slova anglicky Diabetes; Thiamine; Vitamin B1; Transketolase; Benfotiamine; Hyperglycemia; Nephropathy; Metabolic syndrome; Cardiovascular disease; Chronic kidney disease
Štítky EL OK
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 7. 8. 2014 14:26.
Anotace
Growing prevalence of diabetes (type 2 as well as type 1) and its related morbidity due to vascular complications creates a large burden on medical care worldwide. Understanding the molecular pathogenesis of chronic micro-, macro- and avascular complications mediated by hyperglycemia is of crucial importance since novel therapeutic targets can be identified and tested. Thiamine (vitamin B1) is an essential cofactor of several enzymes involved in carbohydrate metabolism and published data suggest that thiamine metabolism in diabetes is deficient. This review aims to point out the physiological role of thiamine in metabolism of glucose and amino acids, to present overview of thiamine metabolism and to describe the consequences of thiamine deficiency (either clinically manifest or latent). Furthermore, we want to explain why thiamine demands are increased in diabetes and to summarise data indicating thiamine mishandling in diabetics (by review of the studies mapping the prevalence and the degree of thiamine deficiency in diabetics). Finally, we would like to summarise the evidence for the beneficial effect of thiamine supplementation in progression of hyperglycemia- related pathology and, therefore, to justify its importance in determining the harmful impact of hyperglycemia in diabetes. Based on the data presented it could be concluded that although experimental studies mostly resulted in beneficial effects, clinical studies of appropriate size and duration focusing on the effect of thiamine supplementation/therapy on hard endpoints are missing at present. Moreover, it is not currently clear which mechanisms contribute to the deficient action of thiamine in diabetes most. Experimental studies on the molecular mechanisms of thiamine deficiency in diabetes are critically needed before clear answer to diabetes community could be given.
Návaznosti
NT13198, projekt VaVNázev: Pentózový cyklus jako potenciální nový terapeutický cíl v prevenci diabetických komplikací
Investor: Ministerstvo zdravotnictví ČR, Pentózový cyklus jako potenciální nový terapeutický cíl v prevenci diabetických komplikací
VytisknoutZobrazeno: 6. 10. 2024 08:49